A Phase 2b, Open-label, Single-arm, Multi-centre Study Assessingthe Efficacy and Safety of Adavosertib as Treatment for Recurrentor Persistent Uterine Serous Carcinoma (ADAGIO)

Project: Research project

Project Details

Description

A Phase 2b, Open-label, Single-arm, Multi-centre Study Assessing the Efficacy and Safety of Adavosertib as Treatment for Recurrent or Persistent Uterine Serous Carcinoma (ADAGIO)
StatusFinished
Effective start/end date8/1/20 → 3/1/23

Funding

  • AstraZeneca

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint